US producer of surgical implants, Stryker, is reportedly planning a takeover offer for British medical device company Smith & Nephew.
Bloomberg cited one of the people familiar with the matter saying that Stryker is planning to make an offer in the next few weeks.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
A significant premium will be offered by Stryker to Smith & Nephew’s share price, possibly in the range of 30%.
Both companies’ representatives declined to comment on the takeover offer.
US-listed shares of Smith & Nephew rose 9.3% to $38 during late afternoon trading on the New York Stock Exchange, while Stryker shares were up 1.9% at $96.81, Reuters reported.
Smith & Nephew manufacture products for arthroscopy, wound management, trauma and clinical therapy, as well as orthopedic reconstruction. The company markets its products in 90 countries.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataSmith & Nephew acquired surgical devices business Oratec Interventions for $310m in 2002. It also acquired Swiss orthopedics business Plus Orthopedics for $889m in 2007.
Stryker provides a diverse array of medical technologies, including reconstructive, medical and surgical, as well as neurotechnology and spine products, which are available in more than 100 countries worldwide.
Image: Smith and Nephew factory in East Riding of Yorkshire, UK. Photo: courtesy of Mtaylor848.
